Justin J. File - 12 Jun 2023 Form 3 Insider Report for MEI Pharma, Inc. (MEIP)

Role
CFO and Corporate Secretary
Signature
/s/ Justin J. File
Issuer symbol
MEIP
Transactions as of
12 Jun 2023
Net transactions value
$0
Form type
3
Filing time
01 Aug 2023, 19:07:38 UTC
Previous filing
08 May 2023
Next filing
17 Jul 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MEIP Stock Option (Right to Buy) 12 Jun 2023 Common Stock 53,302 $7.35 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option shall become exercisable with respect to 25% of the shares subject to the option on June 12, 2024, and the option shall become exercisable with respect to 2.0833% of the shares subject to the option on each of the next 36 calendar months following June 12, 2024.